Insight

A new review summarizing the different antibody-based approaches for targeting cancer cells – Nature Reviews Cancer

Photo generated from nature.com

May 29, 2024, 08:36

A new review summarizing the different antibody-based approaches for targeting cancer cells – Nature Reviews Cancer

Nature Reviews Cancer shared a post on X:

“Don´t miss this review summarizing the different antibody-based approaches for targeting cancer cells including checkpoint inhibitors, bispecific antibodies, and antibody drug conjugates, as well as strategies that improve efficacy and reduce toxicities.”

Read further
Source: Nature Reviews Cancer/X

Andrea van Elsas Antibody drug conjugates Bispecific antibodies cancer checkpoint inhibitors Chetan Bettegowda Drew M. Pardoll Katharine M. Wright Maximilian F. Konig Mitchell Ho Nature Nature Reviews Cancer Nickolas Papadopoulos OncoDaily Oncology review Sandra B. Gabelli Shibin Zhou Suman Paul

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

China Approved DATROWAY (Datopotamab Deruxtecan) for HR-Positive, HER2-Negative Metastatic Breast Cancer

Simon Mooijaart: Patient Perspectives on Antithrombotic Therapy in Advanced Cancer

Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?